Larvol Delta - Cemdisiran-Regulatory-Submissions-Accepted-for-Review-by-FDA-and-EMA-for-the-Treatment-of-Generalized-Myasthenia-Gravis-gMG

cemdisiran (ALN-CC5) - Regeneron

https://www.globenewswire.com/news-release/2026/06/22/3315167/0/en/cemdisiran-regulatory-submissions-accepted-for-review-by-fda-and-ema-for-the-treatment-of-generalized-myasthenia-gravis-gmg.html

Jun 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next